Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in <i>PIK3CA</i> -Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers

Javier Pascual, Nicholas C. Turner, Karen E. Swales et al.|Cancer Discovery|2020

Cited by 67